bioskin has strong experience in the management of aesthetic studies with medical devices as well as with pharmaceuticals, both in single-center as well as multicenter settings. Referring to our established network of dermatological experts and key opinion leaders in the aesthetic field, identification and management of qualified sites with timely patient recruitment is one of bioskin's key strenghts to ensure high-quality results. bioskin provides expertise in conducting Phase I to IV studies for pharmaceuticals as well as investigations within the scope of conformity assessments and post-market clinical follow-ups (EU MDR) for medical devices.

bioskin offers studies for the following treatments:

  • Botulinum toxin
  • Dermal fillers
  • Other injectables
  • Chemical peels
  • Laser treatments
  • Cryotherapy